Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10160733
Methods for producing viloxazine salts and novel polymorphs thereof
granted -
US 10159727
Compositions and methods for combination therapy with dengue virus and dendritic cells
granted -
US 10159733
Stable aqueous formulations of adalimumab
granted -
US 10159732
Stable aqueous formulations of adalimumab
granted -
US 10159765
Tissue engineered devices and methods for making same
granted -
US 10159681
Method for on-demand contraception
granted -
US 10159680
Compositions comprising acidic extracts of mastic gum
granted -
WO 2018227427
DÉRIVÉS DE DIAZÉPANE PONTÉS SUBSTITUÉS ET LEUR UTILISATION
granted -
US 2018362511
DIMERIC CONTRAST AGENTS
granted -
US 10155796
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
granted -
US 10155016
Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
granted -
US 10155003
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 10155011
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
granted -
US 10154975
Solid solution compositions and use in chronic inflammation
granted -
US 10154970
Methods for immunomodulation of cancer and infectious disease therapy
granted -
US 10155743
Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
granted -
US 10155044
Methods and compositions for deterring abuse
granted -
US 10155039
Stable aqueous formulations of adalimumab
granted -
US 10155042
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted -
US 10155020
Compositions and methods for treating hepatitis B
granted -
US 10155014
Cyclic di-AMP induction of type I interferon
granted -
US 10154982
Ketone bodies and ketone body esters as blood lipid lowering agents
granted -
US 10154992
Compounds and methods for treating HIV infection
granted -
US 10154669
Improving color and release profile of resin compositions comprising silver nanoparticles
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.